Zhejiang Jolly Pharmaceutical Co.,LTD (300181.SZ)
CNY 16.91
(1.74%)
CNY 16.91
(1.74%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 853.09 Million CNY | -2.97% |
| 2022 | 879.19 Million CNY | 14.88% |
| 2021 | 765.31 Million CNY | 1.98% |
| 2020 | 750.42 Million CNY | 16.73% |
| 2019 | 642.85 Million CNY | -11.51% |
| 2018 | 726.5 Million CNY | 9.73% |
| 2017 | 662.05 Million CNY | 16.97% |
| 2016 | 565.99 Million CNY | 36.4% |
| 2015 | 414.94 Million CNY | 33.96% |
| 2014 | 309.75 Million CNY | 82.88% |
| 2013 | 169.37 Million CNY | 7.02% |
| 2012 | 158.26 Million CNY | -1.08% |
| 2011 | 159.99 Million CNY | 13.09% |
| 2010 | 141.47 Million CNY | 7.12% |
| 2009 | 132.07 Million CNY | 1.0% |
| 2008 | 130.76 Million CNY | 22.45% |
| 2007 | 106.78 Million CNY | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q3 | 1.23 Billion CNY | 6.82% |
| 2024 Q2 | 1.15 Billion CNY | 20.63% |
| 2024 Q1 | 955.41 Million CNY | 11.99% |
| 2023 FY | 853.09 Million CNY | -2.97% |
| 2023 Q2 | 898.94 Million CNY | 14.42% |
| 2023 Q1 | 785.64 Million CNY | -10.64% |
| 2023 Q3 | 830.18 Million CNY | -7.65% |
| 2023 Q4 | 853.09 Million CNY | 2.76% |
| 2022 Q4 | 879.19 Million CNY | 8.79% |
| 2022 Q2 | 751.68 Million CNY | 6.8% |
| 2022 Q1 | 703.85 Million CNY | -8.03% |
| 2022 FY | 879.19 Million CNY | 14.88% |
| 2022 Q3 | 808.15 Million CNY | 7.51% |
| 2021 Q2 | 738.8 Million CNY | -4.11% |
| 2021 Q1 | 770.45 Million CNY | 2.67% |
| 2021 FY | 765.31 Million CNY | 1.98% |
| 2021 Q4 | 765.31 Million CNY | -14.87% |
| 2021 Q3 | 899 Million CNY | 21.68% |
| 2020 Q3 | 645.6 Million CNY | 0.29% |
| 2020 Q2 | 643.71 Million CNY | -2.97% |
| 2020 FY | 750.42 Million CNY | 16.73% |
| 2020 Q1 | 663.42 Million CNY | 3.2% |
| 2020 Q4 | 750.42 Million CNY | 16.24% |
| 2019 FY | 642.85 Million CNY | -11.51% |
| 2019 Q3 | 666.42 Million CNY | -1.57% |
| 2019 Q1 | 718.88 Million CNY | -1.05% |
| 2019 Q2 | 677.07 Million CNY | -5.82% |
| 2019 Q4 | 642.85 Million CNY | -3.54% |
| 2018 Q3 | 706.07 Million CNY | 4.54% |
| 2018 Q2 | 675.42 Million CNY | 7.25% |
| 2018 FY | 726.5 Million CNY | 9.73% |
| 2018 Q1 | 629.76 Million CNY | -4.88% |
| 2018 Q4 | 726.5 Million CNY | 2.89% |
| 2017 Q2 | 580.05 Million CNY | 12.23% |
| 2017 Q3 | 615.4 Million CNY | 6.09% |
| 2017 Q4 | 662.05 Million CNY | 7.58% |
| 2017 Q1 | 516.82 Million CNY | -8.69% |
| 2017 FY | 662.05 Million CNY | 16.97% |
| 2016 Q1 | 443.29 Million CNY | 6.83% |
| 2016 Q4 | 565.99 Million CNY | 7.43% |
| 2016 FY | 565.99 Million CNY | 36.4% |
| 2016 Q3 | 526.85 Million CNY | -8.87% |
| 2016 Q2 | 578.12 Million CNY | 30.41% |
| 2015 Q2 | 293.4 Million CNY | 5.7% |
| 2015 FY | 414.94 Million CNY | 33.96% |
| 2015 Q4 | 414.94 Million CNY | -8.65% |
| 2015 Q1 | 277.57 Million CNY | -10.39% |
| 2015 Q3 | 454.21 Million CNY | 54.81% |
| 2014 Q4 | 309.75 Million CNY | 7.02% |
| 2014 FY | 309.75 Million CNY | 82.88% |
| 2014 Q3 | 289.42 Million CNY | 37.89% |
| 2014 Q2 | 209.9 Million CNY | -0.32% |
| 2014 Q1 | 210.58 Million CNY | 24.33% |
| 2013 Q3 | 139.2 Million CNY | -3.99% |
| 2013 Q4 | 169.37 Million CNY | 21.68% |
| 2013 FY | 169.37 Million CNY | 7.02% |
| 2013 Q1 | 140.05 Million CNY | -11.51% |
| 2013 Q2 | 144.98 Million CNY | 3.53% |
| 2012 FY | 158.26 Million CNY | -1.08% |
| 2012 Q2 | 146.17 Million CNY | -0.48% |
| 2012 Q3 | 146.95 Million CNY | 0.53% |
| 2012 Q4 | 158.26 Million CNY | 7.7% |
| 2012 Q1 | 146.87 Million CNY | -8.2% |
| 2011 Q3 | 160.28 Million CNY | 7.09% |
| 2011 FY | 159.99 Million CNY | 13.09% |
| 2011 Q4 | 159.99 Million CNY | -0.19% |
| 2011 Q1 | 134.18 Million CNY | -5.15% |
| 2011 Q2 | 149.68 Million CNY | 11.55% |
| 2010 Q2 | 136.99 Million CNY | 0.0% |
| 2010 FY | 141.47 Million CNY | 7.12% |
| 2010 Q4 | 141.47 Million CNY | 0.0% |
| 2009 FY | 132.07 Million CNY | 1.0% |
| 2008 FY | 130.76 Million CNY | 22.45% |
| 2007 FY | 106.78 Million CNY | 0.0% |